Health Trials

Refractory or Relapsed Multiple Myeloma

1

Review clinical trials related to Refractory or Relapsed Multiple Myeloma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study to Compare Pharmacokinetics, Efficacy and Safety of Subcutaneous CT-P44 and Darzalex Faspro in Combination With Lenalidomide and Dexamethasone in Patients With Refractory or Relapsed Multiple Myeloma

This study is a phase 1/3 study to Compare Pharmacokinetics, Efficacy and Safety of Subcutaneous CT-P44 and Darzalex Faspro in Combination with Lenalidomide and Dexamethasone in Patients with Refractory or Relapsed Multiple Myeloma

Participants needed: 486
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: CelltrionUpdated: Aug 15, 2025Locations: 1
Eligibility criteria

Male or female with 18 years of age or older. [+4]

Patient has received daratumumab or any other drug specifically targeting CD38 p... [+2]

Read more